The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2026
Write the words of this act the way you think they should read. Solon shows your change as a redline against the published text and pins it to that exact text, so it can never be applied to wording you did not see.
Change 1
2 Amendment to regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013
(1) Regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (zero or nominal product reimbursement for vaccines and antivirals) is amended as follows. (2) In paragraph (2)— (a) omit “or” at the end of sub-paragraph (ae); and (b) after sub-paragraph (ae), insert— (af) a drug or medicine which is used for vaccinating or immunising people against meningococcal disease caused by— (i) Neisseria meningitidis groups A, C, W and Y bacteria, or (ii) Neisseria meningitidis group B bacteria, if the conditions set out in paragraph (3) are satisfied; (ag) a drug or medicine which is used for vaccinating or immunising people against tetanus, diphtheria and polio, if the conditions set out in paragraph (3) are satisfied; or . (3) In paragraph (3A), for “to (ae)” substitute “to (ag)”.
2 Amendment to regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013
(1) Regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (zero or nominal product reimbursement for vaccines and antivirals) is amended as follows. (2) In paragraph (2)— (a) omit “or” at the end of sub-paragraph (ae); and (b) after sub-paragraph (ae), insert— (af) a drug or medicine which is used for vaccinating or immunising people against meningococcal disease caused by— (i) Neisseria meningitidis groups A, C, W and Y bacteria, or (ii) Neisseria meningitidis group B bacteria, if the conditions set out in paragraph (3) are satisfied; (ag) a drug or medicine which is used for vaccinating or immunising people against tetanus, diphtheria and polio, if the conditions set out in paragraph (3) are satisfied; or . (3) In paragraph (3A), for “to (ae)” substitute “to (ag)”.
One line that says what changes, such as "Halve the dog tax".
Who it helps, what it costs, what it fixes. It is what persuades people to support it.
A proposal here is not law. Support on Solon is evidence that people want the change; the official route says what it takes to make it law.
Sign in to file your proposal. What you have written stays on this page.
Sign in to file itThink it through
Ask what your change would do, who would gain and who would bear a cost, and where something like it is already law. The assistant reads your draft as it stands, cites the law and the studies it finds, and takes no side. What you file stays yours.